Reproducibility and Clinical Usefulness of AARV (Assessment of Ability Related to Vision)
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 121
- 主要终点
- the reproducibility of AARV, and its relationship to standard clinical tests
研究概览
简要总结
To determine the clinical usefulness of a refined third-generation instrument - The Assessment of Ability Related to Vision (AARV) in establishing the amount of disability, charting the detrimental effects of progressive disease and establishing the beneficial effects of treatment
详细描述
This research study is designed to test the usefulness and repeatability of testing how much disability is caused by vision loss due to glaucoma. We are recruiting 100 patients with glaucoma and 20 healthy (have no eye disease) individuals to be enrolled in this study. The healthy study participants will be enrolled in order to describe how a healthy individual will perform on the test designed to assess one's performance when completing ten activities of daily living.
Clinical testing will be conducted by binocular and monocular visual fields, contrast sensitivity and visual acuity. The NEI-VFQ 15 Quality of Life Questionnaire will be used to measure patients perception of how well they are doing.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •All patients 18 yrs of age and older
- •must understand and respond to spoken English and be fully literate.
排除标准
- •Patients with significant neurological problems (like Parkinson's disease), motor problems (like arthritis) or other significant illnesses that may prevent them from completing the testing involved in the study (like advanced heart failure).
- •Patients who have received training related to low vision.
结局指标
主要结局
the reproducibility of AARV, and its relationship to standard clinical tests
时间窗: Day 1, 1 week, 6 months, 1 year
次要结局
- A better estimate of the reproducibility of standard clinical tests.(Day 1, 1 week, 6 months, 1 year)
研究者
George L. Spaeth MD
Principal Investigator
Wills Eye